Article
Copy number alterations and allelic ratio in relation to recurrence of rectal cancer.
BMC genomics - 6 Jun 2015
Goossens-Beumer Inès J, Oosting Jan, Corver Wim E, Janssen Marjolein J F W, Janssen Bart, van Workum Wilbert, Zeestraten Eliane C M, van de Velde Cornelis J H, Morreau Hans, Kuppen Peter J K, van Wezel Tom
Abstract excerpt
BACKGROUND: In rectal cancer, total mesorectal excision surgery combined with preoperative (chemo)radiotherapy reduces local recurrence rates but does not improve overall patient survival, a result that may be due to the harmful side effects and/or co-morbidity of preoperative treatment. New biomarkers are needed to facilitate identification of rectal cancer patients at high risk for local recurrent disease. This...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
